Biotechnology - Buffalo, New York, United States
A new biotechnology start-up focused on the development of an universal Human Papillomavirus (HPV) vaccine to provide prophylaxis against all HPV-related cancers and diseases. Our pilot vaccine, RGVax, promises to provide protection against all 15 oncogenic HPVs and many others that cause various warts.
Gmail
Eventbrite
Google Tag Manager
Facebook Login (Connect)
Mobile Friendly